GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » E10

Syncom Formulation (India) (NSE:SYNCOMF) E10 : ₹0.28 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Syncom Formulation (India)'s adjusted earnings per share data for the three months ended in Dec. 2024 was ₹0.140. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹0.28 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Syncom Formulation (India)'s average E10 Growth Rate was 16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-05), Syncom Formulation (India)'s current stock price is ₹17.14. Syncom Formulation (India)'s E10 for the quarter that ended in Dec. 2024 was ₹0.28. Syncom Formulation (India)'s Shiller PE Ratio of today is 61.21.

During the past 13 years, the highest Shiller PE Ratio of Syncom Formulation (India) was 102.36. The lowest was 26.82. And the median was 49.08.


Syncom Formulation (India) E10 Historical Data

The historical data trend for Syncom Formulation (India)'s E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) E10 Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.22 0.25

Syncom Formulation (India) Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.25 0.25 0.27 0.28

Competitive Comparison of Syncom Formulation (India)'s E10

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Shiller PE Ratio falls into.


;
;

Syncom Formulation (India) E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syncom Formulation (India)'s adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.14/158.3229*158.3229
=0.140

Current CPI (Dec. 2024) = 158.3229.

Syncom Formulation (India) Quarterly Data

per share eps CPI Adj_EPS
201409 0.040 96.780 0.065
201412 0.040 96.780 0.065
201503 0.025 97.163 0.041
201506 0.030 99.841 0.048
201509 0.040 101.753 0.062
201512 0.030 102.901 0.046
201603 0.033 102.518 0.051
201606 0.030 105.961 0.045
201703 0.030 105.196 0.045
201706 0.030 107.109 0.044
201709 0.030 109.021 0.044
201712 0.050 109.404 0.072
201803 0.010 109.786 0.014
201806 0.026 111.317 0.037
201809 0.040 115.142 0.055
201812 0.050 115.142 0.069
201903 0.030 118.202 0.040
201906 0.038 120.880 0.050
201909 0.050 123.175 0.064
201912 0.040 126.235 0.050
202003 0.040 124.705 0.051
202006 0.040 127.000 0.050
202009 0.120 130.118 0.146
202012 0.130 130.889 0.157
202103 0.071 131.771 0.085
202106 0.070 134.084 0.083
202109 0.060 135.847 0.070
202112 0.060 138.161 0.069
202203 0.050 138.822 0.057
202206 0.030 142.347 0.033
202209 0.060 144.661 0.066
202212 0.060 145.763 0.065
202303 0.076 146.865 0.082
202306 0.100 150.280 0.105
202309 0.080 151.492 0.084
202312 0.090 152.924 0.093
202403 0.079 153.035 0.082
202406 0.110 155.789 0.112
202409 0.160 157.882 0.160
202412 0.140 158.323 0.140

Add all the adjusted EPS together and divide 10 will get our e10.


Syncom Formulation (India)  (NSE:SYNCOMF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Syncom Formulation (India)'s Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17.14/0.28
=61.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Syncom Formulation (India) was 102.36. The lowest was 26.82. And the median was 49.08.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Syncom Formulation (India) E10 Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) Headlines

No Headlines